It may one day be possible to detect Alzheimer disease (AD) early and monitor its development or response to treatment with an eye scan. The same research team that in 2011 provided evidence that amyloid-β plaques in retinas of deceased patients with AD correlated with plaque burden in their brains has now shown in a small, proof-of-concept trial that these protein deposits can be detected in the retinas of living patients.
Abbasi J. A Retinal Scan for Alzheimer Disease. JAMA. 2017;318(14):1314. doi:10.1001/jama.2017.15192
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: